# Pericardial Effusion From Acute Myocardial Infarction: Contributing Factors and Prognosis at One Year (EPERICARDIM)

> **NCT05146492** · NA · UNKNOWN · sponsor: **Ramsay Générale de Santé** · enrollment: 200 (estimated)

## Conditions studied

- Acute Myocardial Infarction
- Pericardial Effusion

## Interventions

- **PROCEDURE:** MRI

## Key facts

- **NCT ID:** NCT05146492
- **Lead sponsor:** Ramsay Générale de Santé
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-19
- **Primary completion:** 2023-01-19
- **Final completion:** 2024-07-19
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2021-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05146492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05146492, "Pericardial Effusion From Acute Myocardial Infarction: Contributing Factors and Prognosis at One Year (EPERICARDIM)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05146492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*